Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Rush University Medical Center, Chicago, Illinois, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
UT MD Anderson Cancer Center, Houston, Texas, United States
Department of Cardiac Anesthesiology, Medical University of Gdańsk, Gdańsk, Poland
Medical Universty of Gdańsk, Department of Cardiac and Vascular Surgery, Gdańsk, Poland
Sykehuset i Vestfold HF, Tonsberg, Norway
Duke University, Durham, North Carolina, United States
Technische Universität München, Klinikum rechts der Isar, Department of Anesthesiology, Munich, Bavaria, Germany
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.